Rectal Cancer
Recent findings illuminate research in rectal cancer
Published in Medical Devices and Surgical Technology Week, March 19th, 2006
Study 1: Complete response after chemoradiotherapy (CRT) for rectal cancer might predict a low risk of local recurrence and the appropriateness of local excision.
According to recent research from England, "Local excision is considered inappropriate treatment for T3-T4 rectal adenocarcinomas, as it cannot provide prognostic information regarding lymph node involvement and has a high risk of pelvic recurrence. Preoperative CRT studies in rectal cancer suggest that a pathological complete response (pCR) in the primary tumor provides an excellent long-term...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Anesthesia
T-Line Tensymeter provides noninvasive surgical blood pressure monitoring - Cardiology
Cardiac arrest neurologic outcome improved by automated chest compression device - Medical Devices
Cochlear implant effects on peripheral vestibular system characterized - Neurology
Vertigo vestibular prosthesis prototype developed - Otorhinolaryngology
Laryngeal subglottal pressure assessment with incomplete airflow interruption feasible - Aesthetic Medicine
Despite risks, adults not shying away from cosmetic surgery and other treatments - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
